Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol vs Oral Iron for RLS with IDA
NCT02499354Phase 2Completed
- Sponsor
- Auerbach Hematology Oncology Associates
- Start
- Aug 2014
- Primary completion
- Sep 2021
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ferumoxytol in restless legs syndrome (RLS), iron deficiency anemia (IDA), sponsored by Auerbach Hematology Oncology Associates. Started Aug 2014; status: completed.
02
Drugs
ferumoxytol
03
Conditions
restless legs syndrome (RLS)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT02499354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02499354.